论文部分内容阅读
目的:比较米非司酮米索前列醇配伍依沙吖啶羊膜腔内注射与单纯依沙吖啶羊膜腔内注射两种方法在中孕引产中疗效。方法:对160例怀孕13~27周要求终止妊娠的孕妇,随机分为A、B 2组,每组80例。A组为米非司酮米索前列醇配伍依沙吖啶羊膜腔内注射引产,B组依沙吖啶羊膜腔内注入引产。比较2组的宫缩发动时间、总产程时间、产后出血量、胎盘粘连滞留的例数及引产成功例数。结果:2组宫缩发动时间、总产程、产后出血量及胎盘粘连、滞留的例数差异均有统计学意义,2组对终止中期妊娠的成功率差异无统计学意义。结论:米非司酮米索前列醇配伍依沙吖啶中孕引产可缩短产程,减少并发症,可值得推广。
OBJECTIVE: To compare the efficacy of mifepristone misoprostol combined with amrubicin amniotic intramuscular injection and amoxicillin amniotic intramuscular injection alone in the induction of labor during pregnancy. Methods: A total of 160 pregnant women who required termination of pregnancy for 13-27 weeks of pregnancy were randomly divided into A and B 2 groups, 80 cases in each group. A group of mifepristone misoprostol compatibility ethacridine amniotic intramuscular injection of induced abortion, group B according to amniotic fluid injection of amniotic fluid induced abortion. Comparing the two groups of uterine contracting time, total labor time, postpartum hemorrhage, the number of cases of placental adhesion retention and the number of cases of successful induction of labor. Results: There were significant differences in the number of cases of contractile movement, total labor, postpartum hemorrhage, and placenta accreta in two groups. There was no significant difference between the two groups in the success rate of termination of middle-term pregnancy. Conclusion: Mifepristone misoprostol compatibility with ethacridine in labor induction of labor can shorten the labor process, reduce complications, may be worth promoting.